跳至主要内容
临床试验/ISRCTN06195297
ISRCTN06195297已完成未知

Ongoing 2b/3a inhibition In Myocardial infarction Evaluation

Diagram B.V. (Netherlands)0 个研究点目标入组 950 人开始时间: 2005年9月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
950

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Symptoms of acute myocardial infarction of more than 30 minutes
  • 2. ST segment elevation of >1 mV in 2 adjacent ECG leads, with cumulative ST segment deviation of 6 mm or more
  • 3. Ability to perform PCA within 6 hours after onset of symptoms

排除标准

  • 1. Patient with a contraindication to anticoagulation:
  • a. Present bleeding disorder including gastrointestinal bleeding, hematuria, or known presence of occult blood in the stool prior to randomisation
  • b. Systolic blood pressure persistently exceeding 200 mm Hg and/or diastolic blood pressure exceeding 110 mm Hg at time of enrolment
  • c. Recent (<6 mnd) Stroke or Transient Ischemic Attack
  • 2. Patients with severe renal failure (hemodialysis)
  • 3. Patient with recent (< 30 days) major surgery
  • Participation in another clinical study one year before enrolment

研究者

发起方
Diagram B.V. (Netherlands)

相似试验

Ongoing 2b/3a inhibition In Myocardial infarction... | 临床试验